HOME >> MEDICINE >> NEWS
FDA approved ROZEREM (ramelteon)

LINCOLNSHIRE, Ill., July 22 Takeda Pharmaceuticals North America, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for ROZEREMTM (ramelteon) 8-mg tablets for the treatment of insomnia characterized by difficulty with sleep onset. The FDA approval allows physicians to prescribe ROZEREM for long-term use in adults.

ROZEREM is the first and only prescription sleep medication that has shown no evidence of abuse and dependence and, as a result, has not been designated as a controlled substance by the U.S. Drug Enforcement Administration (DEA). With the exception of ROZEREM, all other prescription medications indicated for insomnia are classified as Schedule IV controlled substances by the DEA. Additionally, ROZEREM is the first prescription insomnia medication with a new therapeutic mechanism of action in 35 years, and will be available for patients by late September.

"People with insomnia are not only affected by their sleeplessness at night; insomnia's impact is also in how they feel and function the next day," said Thomas Roth, Ph.D., director of the Sleep Disorders and Research Center, Detroit, Mich. "Current therapies often used for insomnia work by broadly inhibiting the activity of neurons in the brain. Ramelteon treats insomnia by specifically affecting the activity of neurons in an area of the brain involved in the sleep-wake process, and has been shown to carry no risks of abuse, withdrawal, or dependency, and negligible risk for next-day 'hangover' effects."

"ROZEREM represents an exciting new option in sleep medicine that we anticipate can help millions of people who live with sleepless nights and sluggish days," said Yasuchika Hasegawa, president and chief operating officer of Takeda. "The approval of ROZEREM marks a major milestone for Takeda as we seek to bring innovative therapies to patients in a variety of therapeutic areas."

ROZEREMTM<
'"/>


22-Jul-2005


Page: 1 2

Related medicine news :

1. Did drug reps encourage doctors to prescribe gabapentin for nonapproved uses?
2. NIH scientists honored for FDA-approved cervical cancer vaccine breakthrough
3. Previously approved drugs may be helpful in fatal pediatric disorder
4. Shires DAYTRANA(TM) transdermal patch approved by FDA for treatment of ADHD
5. Higher dose formulation of FOSRENOL approved to reduce serum phosphorus in esrd patients
6. GlaxoSmithKlines Havrix now approved for use in children aged 12 months and older
7. Cedars-Sinais live donor liver transplant program receives unos-approved designation
8. Many drugs prescribed for chronic insomnia are not approved for that purpose
9. Sildenafil (Viagra) approved for treatment of pulmonary arterial hypertension (PAH) as Revatio
10. ROZEREM (ramelteon) shown to be effective in a first-night-effect model of transient
11. ROZEREM (ramelteon) showed significant reduction in time to fall asleep

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/13/2018)... MS (PRWEB) , ... September 13, 2018 , ... ... Nash, are honoring National Gum Care Month to educate their patients and the ... MS, via advanced equipment and procedures. Not only do Drs. Nash have extensive ...
(Date:9/12/2018)... ... September 12, 2018 , ... Definitive Healthcare , the leading provider of ... tournament supporting the Dana-Farber Cancer Institute and the Jimmy Fund. , “It’s a ... director. “I’m happy we have such wonderful sponsors and volunteers. The growth we’ve seen ...
(Date:9/7/2018)... ... September 07, 2018 , ... The OSHA Training ... authorized OTI Education Center headquartered in Northern California, is shining a spotlight on ... experienced retaliation in response to engaging in activity protected under 22 whistleblower statutes. ...
(Date:9/1/2018)... ... ... “Vitamin D is the Key: The Myth, the Reality and the Revolutionary ... in Vitamins and Supplements, Medical Atlases, Vitamins, Medical References, and was recognized as a ... United States. , With all the medical advancements over the last hundred years, vitamin ...
(Date:8/31/2018)... RAPIDS, Mich. (PRWEB) , ... August 31, 2018 ... ... treatment provider, will host an Open House on Wednesday, September 12 from 1:00-3:00 ... options available in Grand Rapids, as well as tour the facility, meet our ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... (PRWEB) , ... September 14, 2018 , ... ... announces the launch of “Carto.graph”. Developed in collaboration with SmithGroup, the Carto.graph collection ... urban landscape. , EnviroLeather™ teamed up with SmithGroup’s healthcare interior designer, Aileen ...
(Date:9/15/2018)... N.C. (PRWEB) , ... September 14, 2018 , ... ... Support campaign to benefit individuals and families affected by Hurricane Florence. , Throughout ... to make financial donations in any amount, or round up their transaction to ...
(Date:9/13/2018)... (PRWEB) , ... September 13, 2018 , ... ... is now available to test and ensure correct implementation of the NCPDP ... SCRIPT Version 2017071 includes important functionality and transactions identified by the industry as ...
Breaking Medicine Technology:
Cached News: